Paper Details

  1. Home
  2. Paper Details

Favourable one-year ART outcomes in adult Malawians with hepatitis B and C co-infection.

Author: BeadsworthM B J, BeechingN J, ChapondaM, DaviesJ, FaragherB, HartI J, HoflandH W C, MhangoB, MooreE, NjalaJ, ZijlstraE E, van OosterhoutJ J

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Viral hepatitis B and C co-infection was not associated with severe hepatotoxicity, mortality, severe morbidity or virological failure in HIV-infected patients starting antiretroviral therapy (ART) in Malawi.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Few studies have investigated the impact of chronic hepatitis B and C infection on antiretroviral therapy (ART) outcomes in sub-Saharan Africa. Hepatotoxicity may be a particular concern in co-infected patients taking nevirapine-stavudine-lamivudine. METHODS: We conducted a prospective ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.jinf.2010.04.009

データ提供：米国国立医学図書館（NLM）

Favorable One-Year ART Outcomes in Adult Malawians with Hepatitis B and C Co-Infection

This research investigates the impact of viral hepatitis B and C co-infection on the effectiveness of antiretroviral therapy (ART) in patients with HIV/AIDS. It's like navigating a desert landscape with multiple challenges, where researchers are looking for the best way to manage the journey. The researchers are studying patients in Malawi, a country in sub-Saharan Africa, to see if ART is effective in managing HIV and hepatitis co-infection.

ART Outcomes in Hepatitis B and C Co-Infected Patients

The researchers found that ART was effective in managing HIV and hepatitis co-infection, despite concerns about potential liver toxicity. This is like finding a safe route through a treacherous desert, where the travelers can navigate the dangers and reach their destination. They observed that the co-infection did not significantly increase the risk of liver damage, mortality, or treatment failure.

Implications for ART Programs in Sub-Saharan Africa

This research provides valuable insights into the management of HIV and hepatitis co-infection in sub-Saharan Africa. It's like finding a new oasis, offering a refreshing solution to a complex health challenge.

Dr.Camel's Conclusion

This research provides reassuring news for patients with HIV and hepatitis co-infection, demonstrating that ART can be a viable treatment option. It's a testament to the power of medical research to find solutions for complex health issues, like a camel caravan discovering a new route to a flourishing oasis.

Date :
  1. Date Completed 2010-11-01
  2. Date Revised 2010-07-26
Further Info :

Pubmed ID

20470823

DOI: Digital Object Identifier

10.1016/j.jinf.2010.04.009

Related Literature

Article Analysis
・Side Effects of stavudine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.